Cornercap Investment Counsel Inc Cytom X Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $329 Million
- Q3 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 41,458 shares of CTMX stock, worth $34,824. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,458
Previous 80,591
48.56%
Holding current value
$34,824
Previous $98,000
51.02%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CTMX
# of Institutions
72Shares Held
49.4MCall Options Held
112KPut Options Held
8.3K-
Tang Capital Management LLC San Diego, CA7.81MShares$6.56 Million0.79% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$4.39 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$4.34 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X04.81MShares$4.04 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.1MShares$2.6 Million0.01% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $55.4M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...